These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2953862)

  • 1. Binding of (+)PHNO and other D2-dopamine agonists to D1-dopamine receptors labelled by [3H]SCH 23390.
    Pettibone DJ; Totaro JA; Clineschmidt BV
    J Neural Transm; 1987; 69(1-2):147-51. PubMed ID: 2953862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active site.
    Braestrup C; Andersen PH
    J Neurochem; 1987 Jun; 48(6):1667-72. PubMed ID: 2952762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist.
    Meller E; Kuga S; Friedhoff AJ; Goldstein M
    Life Sci; 1985 May; 36(19):1857-64. PubMed ID: 3157851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
    Niznik HB; Otsuka NY; Dumbrille-Ross A; Grigoriadis D; Tirpak A; Seeman P
    J Biol Chem; 1986 Jun; 261(18):8397-406. PubMed ID: 3522568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes.
    Tice MA; Hashemi T; Taylor LA; Duffy RA; McQuade RD
    Pharmacol Biochem Behav; 1994 Nov; 49(3):567-71. PubMed ID: 7862709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiographic localisation of D1 and D2 dopamine receptors in primordial striatal tissue grafts in rats.
    Mayer E; Heavens RP; Sirinathsinghji DJ
    Neurosci Lett; 1990 Feb; 109(3):271-6. PubMed ID: 2139499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analyses.
    McQuade RD; Duffy RA; Anderson CC; Crosby G; Coffin VL; Chipkin RE; Barnett A
    J Neurochem; 1991 Dec; 57(6):2001-10. PubMed ID: 1834801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascorbic acid inhibits [3H]SCH-23390 binding to striatal dopamine D1 receptors.
    Wiener HL; Lajtha A; Sershen H
    J Recept Res; 1989; 9(4-5):331-9. PubMed ID: 2531799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired ontogeny of striatal dopamine D1 and D2 binding sites after postnatal treatment of rats with SCH-23390 and spiroperidol.
    Kostrzewa RM; Saleh MI
    Brain Res Dev Brain Res; 1989 Jan; 45(1):95-101. PubMed ID: 2645067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1 and D2 receptor selectivities of agonists and antagonists.
    Seeman P; Ulpian C
    Adv Exp Med Biol; 1988; 235():55-63. PubMed ID: 2976254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
    Gredal O; Nielsen M; Hyttel J
    Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D1 and D2 receptor selectivities of phenyl-benzazepines in rhesus monkey striata.
    Weed MR; Woolverton WL; Paul IA
    Eur J Pharmacol; 1998 Nov; 361(1):129-42. PubMed ID: 9851550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.